Application 007413

Type
NDA
Sponsor
PHARMACIA AND UPJOHN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PROTAMINE SULFATEPROTAMINE SULFATEINJECTABLE;INJECTION50MG/VIALNoNo
002PROTAMINE SULFATEPROTAMINE SULFATEINJECTABLE;INJECTION250MG/VIALNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N007413-001PROTAMINE SULFATEPROTAMINE SULFATE50MG/VIALPOWDER / INTRAVENOUSApproved before 1982
N007413-002PROTAMINE SULFATEPROTAMINE SULFATE250MG/VIALPOWDER / INTRAVENOUS1984-08-02

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09N007413-001PROTAMINE SULFATE50MG/VIALPOWDER / INTRAVENOUSApproved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N007413-002PROTAMINE SULFATE250MG/VIALPOWDER / INTRAVENOUS1984-08-02c2088c7a36db…
2026-09-14 22:38:342026-08N007413-001PROTAMINE SULFATE50MG/VIALPOWDER / INTRAVENOUSApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N007413-002PROTAMINE SULFATE250MG/VIALPOWDER / INTRAVENOUS1984-08-0284e616aacf4f…
2026-08-18 06:07:402026-07N007413-001PROTAMINE SULFATE50MG/VIALPOWDER / INTRAVENOUSApproved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N007413-002PROTAMINE SULFATE250MG/VIALPOWDER / INTRAVENOUS1984-08-02caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N007413-001PROTAMINE SULFATE50MG/VIALPOWDER / INTRAVENOUSApproved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N007413-002PROTAMINE SULFATE250MG/VIALPOWDER / INTRAVENOUS1984-08-02011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N007413-001PROTAMINE SULFATE50MG/VIALPOWDER / INTRAVENOUSApproved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N007413-002PROTAMINE SULFATE250MG/VIALPOWDER / INTRAVENOUS1984-08-0231067a03dcf5…
2025-08-23 18:47 UTC2025-08N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-026a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-02fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-02b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 198203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-0203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 19822680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-022680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 19825bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-025bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 1982d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-02d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 1982d06236e962d9…
2024-10-29 15:01 UTC2024-10N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-02d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 198279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-0279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 1982301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-02301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 19821e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-021e350fbaab3a…
2024-05-31 18:47 UTC2024-05N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 19828072bd15b7f6…
2024-05-31 18:47 UTC2024-05N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-028072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 19825c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-025c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 19825d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-025d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N007413-001PROTAMINE SULFATE50MG/VIALINJECTABLE / INJECTIONApproved before 19824b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N007413-002PROTAMINE SULFATE250MG/VIALINJECTABLE / INJECTION1984-08-024b0b4de00fa7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Protamine SulfatePROTAMINE SULFATEFresenius Kabi USA, LLCc76876da-b9a8-45d0-9278-7df3288d3a062025-04-29Boxed warning, Warnings, Adverse reactionsName fallback
brand name: Protamine Sulfate
generic name: PROTAMINE SULFATE
Protamine SulfatePROTAMINE SULFATEFresenius Kabi USA, LLCe1964129-33f4-4e4e-86e3-8e6a4e65bd832025-02-05Boxed warning, Warnings, Adverse reactionsName fallback
brand name: Protamine Sulfate
generic name: PROTAMINE SULFATE
Protamine SulfatePROTAMINE SULFATEFresenius Kabi USA, LLC7a31fc4c-579f-45cc-9559-39cfad9a57b32024-03-18Boxed warning, Warnings, Adverse reactionsName fallback
brand name: Protamine Sulfate
generic name: PROTAMINE SULFATE
PROTAMINE SULFATEPROTAMINE SULFATEHF Acquisition Co LLC, DBA HealthFirst94d4f57f-940e-c0a8-e053-2a95a90ae3af2024-01-22Boxed warning, Warnings, Adverse reactionsName fallback
brand name: PROTAMINE SULFATE
generic name: PROTAMINE SULFATE
Protamine SulfatePROTAMINE SULFATEFresenius Kabi USA, LLC8df0a819-9e1a-44ce-97a6-3ea82c867d442024-01-18Boxed warning, Warnings, Adverse reactionsName fallback
brand name: Protamine Sulfate
generic name: PROTAMINE SULFATE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.